SciClone Pharmaceuticals (Holdings) Limited (HK:6600) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
SciClone Pharmaceuticals (Holdings) Limited, in collaboration with Silver Pegasus Investment Limited, announced a non-binding letter of support from Pentwater Capital Management Europe LLP for their proposal to privatize the company. This letter signifies Pentwater’s intention to vote in favor of the privatization scheme, but it maintains flexibility in share dealings during the offer period, without creating legal obligations. Investors are cautioned that the proposal’s completion is contingent on fulfilling certain conditions, including approval of special deal rollover arrangements.
For further insights into HK:6600 stock, check out TipRanks’ Stock Analysis page.